17 documents found, page 1 of 2
Venoarterial extracorporeal membrane oxygenation bridge to HeartMate 3: An Iber...
Maltês, S; Rocha, BM; Strong, C; Paiva, MS; Cunha, GJ; Brízido, C; Ramos, M; Ventosa, A; Nolasco, T; Tralhão, A; Aguiar, C; Mendes, M; Pedro Neves, J
Polypill use for the prevention of cardiovascular disease: a position paper
Araújo, F; Caldeira, D; Aguiar, C; Antunes, JP; Cardim, N; Cunha, V; Fonseca, L; Moura, JP; Paixão-Dias, VM; Ribeiro, H; Cruz, VT; Gavina, CCardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, however it is still underused in clinical practice. This paper presents an expert consensus aimed to summarize the data regarding polypill use. The authors consider t...
Polypill use for the prevention of cardiovascular disease: A position paper
Araújo, F; Caldeira, D; Aguiar, C; Antunes, JP; Cardim, N; Cunha, V; Fonseca, L; Moura, JP; Paixão-Dias, VM; Ribeiro, H; Tedim Cruz, V; Gavina, CCardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, however it is still underused in clinical practice. This paper presents an expert consensus aimed to summarize the data regarding polypill use. The authors consider t...
Cuidados Intensivos Cardíacos em Portugal: Projetar a Mudança
Monteiro, S; Timóteo, AT; Caeiro, D; Silva, M; Tralhão, A; Guerreiro, C; Silva, D; Aguiar, C; Santos, J; Monteiro, P; Gil, V; Morais, JIn recent years, the number of patients requiring acute cardiac care has increased, with progressively more complex cardiovascular conditions, often complicated by acute or chronic non-cardiovascular comorbidities, which affects the management and prognosis of these patients. Coronary care units have evolved into cardiac intensive care units, which provide highly specialized health care for the critical heart p...
Suboptimal Lipid Levels in Clinical Practice Among Portuguese Adults With Dysli...
Marques da Silva, P; Aguiar, C; Morais, J; DISGEN-LIPID study InvestigatorsIntroduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Portugal. Hypercholesterolemia has a causal role in atherosclerotic CVD. Guidelines recommend that cardiovascular (CV) risk reduction should be individualized and treatment goals identified. Low-density lipoprotein cholesterol (LDL-C) is the primary treatment target. Methods: DISGEN-LIPID was a cross-sectional observat...
Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients...
Kotseva, K; De Backer, G; De Bacquer, D; Rydén, L; Hoes, A; Grobbee, D; Maggioni, A; Marques-Vidal, P; Jennings, C; Abreu, A; Aguiar, C; Badariene, JAims: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results: ...
Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in pati...
Monteiro, P; Aguiar, C; Matos, P; Silva-Nunes, J; Birne, R; Branco, P; Calado, J; Melo, M; Polónia, JThe prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the inclusion of CV endpoints in clinical trials on the treatment of T2D. This article explores the various trials already performed and under development in this field, with particular focus on the EMPA-REG OUTCOME trial. In this trial, empagliflozin, a sodium-glucose co-transporter 2 ...
Peritoneum Patch Repair in Oncologic Major Resections – An Autolog Alternative
Aguiar, C; Vigia, E; Nobre, AM; Bicho, L; Filipe, E; Paulino, J
CODAP: a Multidisciplinary Consensus Among Portuguese Experts on the Definition...
Mello e Silva, A; Aguiar, C; Sequeira Duarte, J; Couto, L; Teixeira Veríssimo, M; Marques da Silva, PIntroduction and aims: Atherogenic dyslipidemia is an important contributor to residual cardiovascular (CV) risk, but it is underdiagnosed and undertreated. This study aimed to assess the opinion of Portuguese experts to generate a consensus concerning the diagnosis and treatment of atherogenic dyslipidemia, as well as to contribute toward standardization of clinical practice in this disorder. Methods: The stud...
Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Pati...
Monteiro, P; Aguiar, C; Matos, P; Silva-Nunes, J; Birne, R; Branco, P; Calado, J; Melo, M; Polónia, JThe prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the inclusion of CV endpoints in clinical trials on the treatment of T2D. This article explores the various trials already performed and under development in this field, with particular focus on the EMPA-REG OUTCOME trial. In this trial, empagliflozin, a sodium-glucose co-transporter 2 ...